{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:59:54Z","timestamp":1767963594145,"version":"3.49.0"},"reference-count":43,"publisher":"BMJ","issue":"9","funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Breast Cancer Association"},{"name":"Stockholm Cancer Society"},{"name":"Stockholm County Council Research Strategy Committee"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007230","name":"Stiftelsen Konung Gustaf V:s Jubileumsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2018,3,13]]},"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The accuracy of biomarker assessment in breast pathology is vital for therapy decisions. The therapy predictive and prognostic biomarkers oestrogen receptor (ER), progesterone receptor, HER2 and Ki67 may act as surrogates to gene expression profiling of breast cancer. The aims of this study were to investigate the concordance of consecutive biomarker assessment by immunocytochemistry on preoperative fine-needle aspiration cytology versus immunohistochemistry (IHC) on the corresponding resected breast tumours. Further, to investigate the concordance with molecular subtype and correlation to stage and outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two retrospective cohorts comprising 385 breast tumours with clinicopathological data including gene expression-based subtype and up to 10-year overall survival data were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In both cohorts, we identified a substantial variation in Ki67 index between cytology and histology and a switch between low and high proliferation within the same tumour in 121\/360 cases. ER evaluations were discordant in only 1.5% of the tumours. From cohort 2, gene expression data with PAM50 subtype were used to correlate surrogate subtypes. IHC-based surrogate classification could identify the correct molecular subtype in 60% and 64% of patients by cytology (n=63) and surgical resections (n=73), respectively. Furthermore, high Ki67 in surgical resections but not in cytology was associated with poor overall survival and higher probability for axillary lymph node metastasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study shows considerable differences in the prognostic value of Ki67 but not ER in breast cancer depending on the diagnostic method. Furthermore, our findings show that both methods are insufficient in predicting true molecular subtypes.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jclinpath-2017-204976","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T16:15:22Z","timestamp":1522167322000},"page":"787-794","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer"],"prefix":"10.1136","volume":"71","author":[{"given":"Stephanie","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"St\u00e5lhammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Darai-Ramqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Rantalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-8527","authenticated-orcid":false,"given":"Johan","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"2024053001290175000_71.9.787.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1370"},{"key":"2024053001290175000_71.9.787.2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds586"},{"key":"2024053001290175000_71.9.787.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv221"},{"key":"2024053001290175000_71.9.787.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt303"},{"key":"2024053001290175000_71.9.787.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr304"},{"key":"2024053001290175000_71.9.787.6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt306"},{"key":"2024053001290175000_71.9.787.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037379","article-title":"How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists","volume":"7","author":"Varga","year":"2012","journal-title":"PLoS One"},{"key":"2024053001290175000_71.9.787.8","unstructured":"Grabau D . Quality and Standardization Committee (KVAST). Quality- and standadization document for breast tumors. Alings\u00e5s, Sweden: Swedish Society of Pathology\/Swedish Society of Clinical Cytology, 2014."},{"key":"2024053001290175000_71.9.787.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.2482"},{"key":"2024053001290175000_71.9.787.10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2771"},{"key":"2024053001290175000_71.9.787.11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp028"},{"key":"2024053001290175000_71.9.787.12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/his.12344","article-title":"Low concordance of biomarkers in histopathological and cytological material from breast cancer","volume":"64","author":"St\u00e5lhammar","year":"2014","journal-title":"Histopathology"},{"key":"2024053001290175000_71.9.787.13","doi-asserted-by":"crossref","first-page":"38037","DOI":"10.1038\/srep38037","article-title":"Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers","volume":"6","author":"Rantalainen","year":"2016","journal-title":"Sci Rep"},{"key":"2024053001290175000_71.9.787.14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/modpathol.2016.34","article-title":"Digital image analysis outperforms manual biomarker assessment in breast cancer","volume":"29","author":"St\u00e5lhammar","year":"2016","journal-title":"Mod Pathol"},{"key":"2024053001290175000_71.9.787.15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13058-016-0710-8","article-title":"Determining breast cancer histological grade from RNA-sequencing data","volume":"18","author":"Wang","year":"2016","journal-title":"Breast Cancer Res"},{"key":"2024053001290175000_71.9.787.16","unstructured":"Lester S , Bose S , Chen Y-Y , et al . Protocol for the examination of specimens from patients with invasive carcinoma of the breast: College of American Pathologists, 2016."},{"key":"2024053001290175000_71.9.787.17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr393"},{"key":"2024053001290175000_71.9.787.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4134"},{"key":"2024053001290175000_71.9.787.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221505"},{"issue":"Suppl 2","key":"2024053001290175000_71.9.787.20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24 Suppl 2","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"2024053001290175000_71.9.787.21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw050"},{"key":"2024053001290175000_71.9.787.22","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-5-44"},{"key":"2024053001290175000_71.9.787.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2010.11.003"},{"key":"2024053001290175000_71.9.787.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.1268"},{"key":"2024053001290175000_71.9.787.25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0239"},{"key":"2024053001290175000_71.9.787.26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1535"},{"key":"2024053001290175000_71.9.787.27","first-page":"147","article-title":"Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein","volume":"2","author":"Domagala","year":"1996","journal-title":"Clin Cancer Res"},{"key":"2024053001290175000_71.9.787.28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11188"},{"key":"2024053001290175000_71.9.787.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603756"},{"key":"2024053001290175000_71.9.787.30","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi352"},{"key":"2024053001290175000_71.9.787.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70262-1"},{"key":"2024053001290175000_71.9.787.32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.501"},{"key":"2024053001290175000_71.9.787.33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp082"},{"key":"2024053001290175000_71.9.787.34","unstructured":"Regional Cancer Center. National care program breast cancer. Stockholm, Sweden: Regional Cancer Center, 2018."},{"key":"2024053001290175000_71.9.787.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.2835"},{"key":"2024053001290175000_71.9.787.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.2808"},{"key":"2024053001290175000_71.9.787.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2013.11.007"},{"key":"2024053001290175000_71.9.787.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191367098"},{"key":"2024053001290175000_71.9.787.39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0932692100"},{"key":"2024053001290175000_71.9.787.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112121","article-title":"Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays","volume":"9","author":"Knutsvik","year":"2014","journal-title":"PLoS One"},{"key":"2024053001290175000_71.9.787.41","first-page":"425","article-title":"Mib-1 proliferation index is an independent predictor of lymph node metastasis in invasive breast cancer: a prospective study on 675 patients","volume":"15","author":"Marrelli","year":"2006","journal-title":"Oncol Rep"},{"key":"2024053001290175000_71.9.787.42","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1847"},{"key":"2024053001290175000_71.9.787.43","first-page":"1716","article-title":"Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer","volume":"7","author":"Liu","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2017-204976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T15:48:46Z","timestamp":1717084126000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2017-204976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,15]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/jclinpath-2017-204976"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2017-204976","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]}}}